142 related articles for article (PubMed ID: 37223120)
1. Predictive value of immunoglobulin G, activated partial thromboplastin time, platelet, and indirect bilirubin for delayed viral clearance in patients infected with the Omicron variant.
Zhang L; Xie S; Lyu F; Liu C; Li C; Liu W; Ma X; Zhou J; Qian X; Lu Y; Qian Z
PeerJ; 2023; 11():e15443. PubMed ID: 37223120
[TBL] [Abstract][Full Text] [Related]
2. Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patients.
He S; Fang Y; Yang J; Wang W
Front Public Health; 2022; 10():1032957. PubMed ID: 36620263
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and risk factors analysis of viral shedding time in mildly symptomatic and asymptomatic patients with SARS-CoV-2 Omicron variant infection in Shanghai.
Li R; Jin C; Zhang L; Kong D; Hu K; Xuan M; Liu Q; Li S; Zhang K; Xue Y
Front Public Health; 2022; 10():1073387. PubMed ID: 36684919
[TBL] [Abstract][Full Text] [Related]
4. Comorbidities prolonged viral shedding of patients infected with SARS-CoV-2 omicron variant in Shanghai: A multi-center, retrospective, observational study.
Pei L; Chen Y; Zheng X; Gong F; Liu W; Lin J; Zheng R; Yang Z; Bi Y; Chen E
J Infect Public Health; 2023 Feb; 16(2):182-189. PubMed ID: 36566602
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with prolonged viral shedding in older patients infected with Omicron BA.2.2.
Zhong W; Yang X; Jiang X; Duan Z; Wang W; Sun Z; Chen W; Zhang W; Xu J; Cheng J; Yuan X; Li Y
Front Public Health; 2022; 10():1087800. PubMed ID: 36711364
[TBL] [Abstract][Full Text] [Related]
6. Chronological changes of viral shedding in adult inpatients with Omicron infection in Shanghai, China.
Zhou X; Huang X; Sun T; Jin X; Tian Z; Xue M; Kang J; Gao B; Xu A; Chen Y; Jia Y; Liu S
Front Immunol; 2023; 14():1090498. PubMed ID: 36817453
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for progression to severe infection and prolonged viral clearance time in hospitalized elderly patients infected with the Omicron variant of SARS-CoV-2: a retrospective study at Shanghai Fourth People's Hospital, School of Medicine, Tongji University.
Tang S; Man Q; Zhu D; Yu X; Chen R; Wang S; Lu Y; Shi Q; Suo C; Xiong L
Front Microbiol; 2024; 15():1361197. PubMed ID: 38686116
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors and RT-PCR profile of prolonged viral shedding in patients with SARS-CoV-2 Omicron variant in Shanghai: A retrospective observational study.
Zhang W; Zhou S; Wang G; Cao M; Sun D; Lu W; Shi L; Guo Y; Xu X; Pu Y; Chen C; Yang H; Sun Y; Hu H; Fang B
Front Public Health; 2022; 10():1015811. PubMed ID: 36353283
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics and related factors of viral nucleic acid negative conversion in children infected with Omicron variant strain of SARS-CoV-2].
Yin R; Lu Q; Jiao JL; Lin K; Wang C; Yuan L; Ding Y; Dong N; Wang BJ; Niu YH; Fang YS; Liu W; Sun YF; Zou B; Zhang XE; Xiao P; Sun L; Du X; Zhu YY; Dong XY
Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1307-1311. PubMed ID: 36444435
[No Abstract] [Full Text] [Related]
10. Factors associated with negative conversion of viral RNA in hospitalized children infected with SARS-CoV-2 Omicron variant in Shanghai, China: a retrospective analysis.
Yang Y; You Y; Liu Y; Geng L; Huang L; Zhou H; Piao X; Liu X; Wu M; Wang Y; Zhou L; Wang P; Shen S; Hu M; Han Z; Xue Z
BMC Infect Dis; 2023 Apr; 23(1):264. PubMed ID: 37101288
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of 310 SARS-CoV-2 Omicron variant patients and comparison with Delta and Beta variant patients in China.
Yang W; Yang S; Wang L; Zhou Y; Xin Y; Li H; Mu W; Wu Q; Xu L; Zhao M; Wang C; Yu K
Virol Sin; 2022 Oct; 37(5):704-715. PubMed ID: 35948265
[TBL] [Abstract][Full Text] [Related]
12. Contributing Factors Affecting the Length of Hospital Stay among Febrile Patients with Omicron Reported in Suzhou.
Xu L; Ying Y; Xie J; Shen X; Zhu F; Chen J; Shen D
Clin Lab; 2024 May; 70(5):. PubMed ID: 38747918
[TBL] [Abstract][Full Text] [Related]
13. A Nomogram for Predicting Delayed Viral Shedding in Non-Severe SARS-CoV-2 Omicron Infection.
Yu T; Dong J; Qi Q; Lv Q; Li J; Huang C; Cai X
Infect Drug Resist; 2023; 16():2487-2500. PubMed ID: 37138833
[TBL] [Abstract][Full Text] [Related]
14. Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study.
Xu N; Pan J; Sun L; Zhou C; Huang S; Chen M; Zhang J; Zhu T; Li J; Zhang H; Gao Y
Front Immunol; 2022; 13():967716. PubMed ID: 35990674
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study.
Malahe SRK; Hoek RAS; Dalm VASH; Broers AEC; den Hoed CM; Manintveld OC; Baan CC; van Deuzen CM; Papageorgiou G; Bax HI; Van Kampen JJ; Hellemons ME; Kho MML; de Vries RD; Molenkamp R; Reinders MEJ; Rijnders BJA
Clin Infect Dis; 2023 Feb; 76(3):e172-e178. PubMed ID: 35869843
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections.
Saade C; Brengel-Pesce K; Gaymard A; Trabaud MA; Destras G; Oriol G; Cheynet V; Debombourg M; Mokdad B; Billaud G; Oblette A; Créhalet H; Giannoli JM; Garrigou C; Generenaz L; Compagnon C; Boibieux A; Lina B; Morfin F; Pozzetto B; Josset L; Trouillet-Assant S; Bal A
Emerg Microbes Infect; 2022 Dec; 11(1):2423-2432. PubMed ID: 36098494
[TBL] [Abstract][Full Text] [Related]
17. Association of clinical characteristics and vaccines with risk of persistently viral clearance in patients infected with SARS-CoV-2 Omicron variant in Shanghai, China.
Zhang W; Wu H; Guo Q; Xu X; Pu Y; Chen C; Cao M; Sun D; Lu W; Yi H; Zhou S; Fang B
Heliyon; 2024 Jan; 10(1):e23256. PubMed ID: 38192786
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 omicron variant clearance delayed in breakthrough cases with elevated fasting blood glucose.
Zhang X; Si G; Lu H; Zhang W; Zheng S; Huang Z; Liu L; Xue Y; Zheng G
Virol J; 2022 Sep; 19(1):148. PubMed ID: 36100916
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of the neutralizing antibodies after the booster dose on SARS-CoV-2 Omicron variant and a two-year longitudinal antibody study on Wild Type convalescents.
Zheng Y; Pan J; Jin M; Wang J; Tung TH; Chen S; Bi X; Zhou K; Chen M; Wang D; Li J; Shen B; Ying L
Int Immunopharmacol; 2023 Jun; 119():110151. PubMed ID: 37044040
[TBL] [Abstract][Full Text] [Related]
20. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
